Form 4 Tracker
Pasithea Therapeutics Corp.
KTTA

8 insider filings · Latest: Jun 17, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Jun 17, 2026Jun 22 2:30 PMCoastlands Capital LP10% Owner
Purchase
100,000$0.53$53.0K3,835,035(I)

View →

May 12, 2025May 15 1:55 AMTiago Reis Marques
Proposed Sale
960$0.831$798

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
May 1, 2026May 5 8:42 PMTiago MarquesDirector, Chief Executive Officer
Grant/Award
1,756,069$0.8411,756,069(D)

View →

May 1, 2026May 5 8:42 PMSTEINMAN LAWRENCEDirector
Grant/Award
152,783$0.841152,783(D)

View →

May 1, 2026May 5 8:41 PMSimon DumesnilDirector
Grant/Award
152,783$0.841152,783(D)

View →

May 1, 2026May 5 8:41 PMDaniel H SchneidermanChief Financial Officer
Grant/Award
1,129,323$0.8411,129,323(D)

View →

May 1, 2026May 5 8:41 PMKartik KrishnanChief Medical Officer
Grant/Award
1,129,323$0.8411,129,323(D)

View →

May 1, 2026May 5 8:41 PMEmer LeahyDirector
Grant/Award
152,783$0.841152,783(D)

View →

May 1, 2026May 5 8:40 PMAlfred J NovakDirector
Grant/Award
152,783$0.841152,783(D)

View →